Nachrichten zur Moderna Inc. Aktie

Coronavirus tally: Moderna promises to keep COVID vaccine available and free for all Americans

Moderna Inc. will keep its COVID-19 vaccines available and free for all people in the U.S. after the public-health…

Moderna CEO to testify in senate on proposed vaccine price hike

...(Reuters) - Senator Bernie Sanders said on Wednesday Moderna......…

Moderna Inc. stock outperforms market on strong trading day

Moderna Inc. stock outperforms market on strong trading day...…

Moderna promises to keep COVID vaccine free

Moderna Inc. MRNA said Tuesday it will keep its COVID-19 vaccines available and free for all people in the U.S.…

Moderna CEO to face Senate hearing over pricing for COVID shot

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Moderna CEO Stephane Bancel will testify before Senate next month on Covid vaccine price hike

Um den gesamten Artikel unter cnbc.com zu lesen, klicken Sie bitte auf die Überschrift...…

Federal government, not Moderna, should face COVID vaccine patent lawsuit, DoJ says

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

U.S. backs Moderna, says government should face COVID-19 vaccine lawsuit

...By Blake Brittain (Reuters) - The U.S. government should face......…

Moderna to offer free COVID shots even after pandemic emergency

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Moderna Inc. stock outperforms competitors on strong trading day

Moderna Inc. stock outperforms competitors on strong trading day...…

Moderna (MRNA) Outpaces Stock Market Gains: What You Should Know

Moderna (MRNA) closed the most recent trading day at $171.48, moving +1.3% from the previous trading session....…

Insiderhandel: President verkauft Aktien von Moderna im Wert von 40.156$

Hoge, Stephen - Vorstand - Tag der Transaktion: 2023-02-10...…

Moderna Inc. stock rises Monday, still underperforms market

Moderna Inc. stock rises Monday, still underperforms market...…

Moderna, Cirrus Logic And Other Balance Sheet Powerhouses

These U.S. companies with market caps of at least $5 billion have earnings of at least 20 cents a share…

Insiderhandel: Aufsichtsrat verkauft Aktien von Moderna im Wert von 3.356.761$

Afeyan, Noubar - Aufsichtsrat - Tag der Transaktion: 2023-02-08...…

Fact Check-Moderna CEO did not say company made 100,000 COVID-19 vaccine doses before the pandemic started

...By Reuters Fact Check At Davos 2023, Moderna CEO Stephane Bancel.../pfbid02TsXTLtfZfs4kB4o4KWjwbYHtKJ4YQzNXZEUFgJxXxhqdwiMmBYY5FywYwP1eTRUnl). …

Moderna Inc. stock outperforms market on strong trading day

Moderna Inc. stock outperforms market on strong trading day...…

Corona-Impfstoffe von BioNTech und Moderna: Das ändert sich bald in den USA – die Folgen

Deutschland, die USA und viele Länder haben im Zuge der Corona-Pandemie Hunderte Millionen Impfdosen für ihre Länder bestellt. Nun will…

Bivalent COVID Vaccines Perform Worse Against Variant Now Dominant In United States: Studies

Bivalent COVID Vaccines Perform Worse Against Variant Now Dominant In United States: Studies …

Moderna, Inc. (MRNA) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching Moderna (MRNA) quite a bit. Thus, it is worth knowing the facts that could…

What Fauci Knew About Vaccine Ineffectiveness... And When

What Fauci Knew About Vaccine Ineffectiveness... And When Authored…

Moderna (MRNA) Gains But Lags Market: What You Should Know

Moderna (MRNA) closed the most recent trading day at $171.06, moving +0.46% from the previous trading session....…

Moderna Inc. stock rises Tuesday, still underperforms market

Moderna Inc. stock rises Tuesday, still underperforms market...…

Carisma Therapeutics Appoints Moderna CSO of External Research Ventures, Lin Guey, to Scientific Advisory Board

PHILADELPHIA, Feb. 7, 2023 /PRNewswire/ -- Carisma Therapeutics Inc., a clinical stage biopharmaceutical company focused on discovering and developing innovative…

Experts Want Labels For Pfizer, Moderna COVID-19 Vaccines Updated To Acknowledge Limitations

Experts Want Labels For Pfizer, Moderna COVID-19 Vaccines Updated To Acknowledge Limitations …

Moderna Inc. stock underperforms Monday when compared to competitors

Moderna Inc. stock underperforms Monday when compared to competitors...…

CANSINOBIO Says Its Experimental Vaccine Works as Good as Moderna and Pfizers

Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...…

Moderna Inc. stock underperforms Friday when compared to competitors

Moderna Inc. stock underperforms Friday when compared to competitors...…

Personalis Stock Jumps on Cancer-Vaccine Agreement with Moderna

Personalis Stock Jumps on Cancer-Vaccine Agreement with Moderna...…

Personalis Moderna sign agreement to use NeXT platform for mRNA cancer vaccine trials

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Personalis, Moderna Continue Partnership On Personalized Cancer Vaccine Program

KENILWORTH (NJ) (dpa-AFX) - Personalis Inc. (PSNL) said that it signed a new agreement with Moderna Inc. (MRNA) to continue…

Is Moderna Stock a Buy Now?

The company is starting the year on a strong note....…

Moderna Inc. stock rises Thursday, still underperforms market

Moderna Inc. stock rises Thursday, still underperforms market...…

Moderna, Inc.: Moderna to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 23, 2023

CAMBRIDGE, MA / ACCESSWIRE / February 2, 2023 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics…

Moderna (MRNA) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Moderna (MRNA) closed at $174.30, marking a -1% move from the previous day....…

Moderna Inc. stock falls Wednesday, underperforms market

Moderna Inc. stock falls Wednesday, underperforms market...…

Dow Jones & Co deutlich im Plus: Home Depot, Tesla, BioNTech und AMD stark, Caterpillar, Snap und Moderna kräftig unter Druck – der Tag an der Wall Street

Die New Yorker Börsen haben nach einem schwachen Wochenbeginn am Dienstag deutlich Boden gut gemacht. Die Standardwerte-Indizes machten dank eines…

This Discount Growth Stock Is a Once-in-a-Decade Buying Opportunity Right Now

Moderna stock has dropped 60% from its peak....…

Moderna’s stock is down as Pfizer lowers revenue estimates for its COVID vaccine for 2023

Moderna Inc.’s MRNA shares were down 2.8% in trading on Tuesday. Pfizer Inc. PFE, which makes a competing COVID-19 vaccine…

The end of the Covid health emergency wont slow FDA clearance of shots and treatments

The FDA has used separate emergency powers to authorize the Pfizer, Moderna, Johnson & Johnson and Novavax vaccines....…

Why BioNTech And Moderna Shares Are Falling After Pfizer News

BioNTech SE - ADR (NASDAQ: BNTX) and Moderna Inc (NASDAQ: MRNA) shares are trading lower Tuesday morning in sympathy with Pfizer…

Dow Jones & Co mit Verlusten: Goldman Sachs, Kraft Heinz und CureVac stark, Tesla, Lucid, Johnson & Johnson, Nvidia, Moderna und Microsoft unter Druck – der Tag an der Wall Street

Die zuletzt freundlichen US-Aktienmärkte sind am Montag schwach in eine ereignisreiche Woche gestartet. Vor allem an der Nasdaq-Börse dominierte vor…

Moderna Inc. stock underperforms Monday when compared to competitors

Moderna Inc. stock underperforms Monday when compared to competitors...…

Fact Check-Vaccine work before SARS-CoV-2 had a name does not prove pandemic was planned

...By Reuters Fact Check U.S. biotech company Moderna Inc announced its...), and Ebola, according to Reuters reporting at the time (https......…

Moderna Gets FDA Breakthrough Designation for RSV Vaccine Candidate >MRNA

Moderna Gets FDA Breakthrough Designation for RSV Vaccine Candidate >MRNA...…

Moderna wins FDA’s breakthrough status for RSV vaccine

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Moderna, Inc.: Moderna Granted FDA Breakthrough Therapy Designation for mRNA-1345, An Investigational Respiratory Syncytial Virus Vaccine Candidate

Designation based on positive topline data from the ConquerRSV Phase 3 pivotal efficacy trial, which demonstrated vaccine efficacy of 83.7%…

dpa-AFX ProFeed